Cipla secures exclusive rights to market Formosa Pharmaceuticals’ APP13007 across 11 countries
Cipla Limited has expanded its presence in the ophthalmology market through a multi-regional licensing agreement with Formosa Pharmaceuticals, granting it exclusive rights to commercialize APP13007, ... Read More
Formosa Pharmaceuticals, Cristália forge licensing deal for APP13007 in Brazil
Formosa Pharmaceuticals, a leading Taiwan-based pharmaceutical company, has announced a landmark licensing agreement with Cristália Produtos Químicos Farmacêuticos LTDA. This deal grants Cristália exclusive rights ... Read More